Correspondence 0001104659-24-103787 from Cytosorbents Corp (CTSO) (CIK 0001175151) (CTSO)
Cytosorbents Corp (CTSO) (CIK 0001175151)
Date: Sept. 27, 2024 · CIK: 0001175151 · Accession: 0001104659-24-103787
AI Filing Summary & Sentiment
File numbers found in text: 333-281062
Letter
CytoSorbents Corporation
305 College Road East
Princeton, New Jersey 08540
(732) 329-8885
September 27, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Benjamin Richie
Re: CytoSorbents Corporation
Registration Statement on Form S-3
Filed July 26, 2024
File No. 333-281062
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, CytoSorbents Corporation hereby requests acceleration of the effective date of the above referenced registration statement so that such registration statement may become effective at 4:00 P.M. (Washington, D.C. time) on September 30, 2024, or as soon as practicable thereafter.
CytoSorbents Corporation
By: /s/ Dr. Phillip P. Chan
Name: Dr. Phillip P. Chan
Title: Chief Executive Officer
Show Raw Text
CORRESP 1 filename1.htm CytoSorbents Corporation 305 College Road East Princeton, New Jersey 08540 (732) 329-8885 September 27, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Benjamin Richie Re: CytoSorbents Corporation Registration Statement on Form S-3 Filed July 26, 2024 File No. 333-281062 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, CytoSorbents Corporation hereby requests acceleration of the effective date of the above referenced registration statement so that such registration statement may become effective at 4:00 P.M. (Washington, D.C. time) on September 30, 2024, or as soon as practicable thereafter. CytoSorbents Corporation By: /s/ Dr. Phillip P. Chan Name: Dr. Phillip P. Chan Title: Chief Executive Officer